GNH USA

Europe — EMA

Mirabegron Avansor

GNH USA supplies Mirabegron Avansor (Mirabegron), a β3‑adrenergic agonist for overactive bladder, urgency and urge incontinence. Request a quote for supply.

Mirabegron

Request sourcing

1
Pack/s

What is Mirabegron?

Mirabegron, the active ingredient in Mirabegron Avansor, is a β3‑adrenergic receptor agonist presented as an oral dosage form for oral use. It treats overactive bladder symptoms such as urgency, frequency and urge urinary incontinence in adults.

GNH USA supplies Mirabegron Avansor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Mirabegron used for?

Mirabegron is indicated for conditions related to overactive bladder, a disorder of detrusor muscle activity. - Overactive bladder: improves bladder capacity and reduces urgency episodes. - Urinary urgency: lessens the sudden need to void. - Urge urinary incontinence: decreases frequency of involuntary leakage.

What are the side effects of Mirabegron?

Common Side Effects: - Hypertension - Nasopharyngitis - Urinary tract infection - Headache - Constipation - Dry mouth

Serious or Rare Side Effects: - Acute urinary retention - Severe hypertension - Angioedema - Myocardial infarction - Anaphylaxis - Significant bladder pain

What precautions apply to Mirabegron?

Before initiating therapy, consider the following safety measures. - Assess blood pressure: monitor for hypertension, especially in patients with cardiovascular risk. - Evaluate renal function: adjust use in severe renal impairment. - Review concomitant β‑agonists: avoid additive sympathomimetic effects. - Caution in elderly: increased susceptibility to urinary retention. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Mirabegron interact with?

Mirabegron may interact with several drug classes; monitoring is advised. Major Interactions (Avoid): - Strong CYP2D6 inhibitors (e.g., fluoxetine) – may increase mirabegron exposure. - Strong CYP3A4 inducers (e.g., rifampin) – may reduce efficacy. - Antihypertensive agents – additive blood‑pressure‑lowering effect. Moderate Interactions (Monitor Closely): - Diuretics – may affect fluid balance and blood pressure. - Anticholinergic bladder agents – overlapping mechanisms may reduce efficacy. - Warfarin – monitor INR for possible interaction.

Frequently asked questions

What is Mirabegron Avansor used for?+
Mirabegron Avansor is prescribed to manage symptoms of overactive bladder, including urinary urgency, frequency, and urge urinary incontinence. It helps increase bladder capacity and reduces involuntary contractions, improving daily comfort for affected adults.
How does mirabegron work in the body?+
Mirabegron selectively stimulates β3‑adrenergic receptors on the detrusor muscle of the bladder. This activation relaxes the smooth muscle during the storage phase, allowing the bladder to hold more urine and decreasing the frequency of sudden urges to void.
What is the usual dose of Mirabegron Avansor?+
The appropriate dose of Mirabegron Avansor is determined by the prescribing healthcare professional based on individual patient factors such as age, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Mirabegron Avansor safe during pregnancy or breastfeeding?+
Safety data for Mirabegron Avansor in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made together with a qualified healthcare provider.
How do I order Mirabegron Avansor from GNH USA?+
To order Mirabegron Avansor, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mirabegron compare with anticholinergic bladder drugs?+
Mirabegron belongs to a different class (β3‑adrenergic agonist) than anticholinergic agents. While both aim to reduce bladder overactivity, mirabegron works by relaxing detrusor muscle via β3 receptors, often resulting in a lower incidence of dry mouth and constipation, which are common with anticholinergics.
What are the storage and handling requirements for Mirabegron Avansor?+
Mirabegron Avansor should be stored at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight or extreme heat to maintain potency.
How is Mirabegron Avansor administered?+
Mirabegron Avansor is taken orally, usually once daily with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise instructed.
What are the most serious risks associated with Mirabegron Avansor?+
Serious risks, though uncommon, include acute urinary retention, severe hypertension, angioedema, myocardial infarction, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like sudden inability to urinate, chest pain, swelling of the face or throat, or rash.
Who should not use Mirabegron Avansor?+
Mirabegron Avansor is contraindicated in patients with known hypersensitivity to mirabegron or any of its excipients. Caution is advised for individuals with uncontrolled hypertension, severe renal impairment, or those taking strong CYP2D6 inhibitors or CYP3A4 inducers without appropriate dose adjustments.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mirabegron
Route
Oral Use
Manufacturer
Avansor Pharma Oy
Origin
EU

Related products

Myrbetriq 25 mg/1

Myrbetriq 25 mg/1

Mirabegron · 25 mg

Myrbetriq
TABLET, FILM COATED, EXTENDED RELEASE
Astellas Pharma US, Inc.
USA
Myrbetriq 25 mg/1

Myrbetriq 25 mg/1

Mirabegron · 25 mg

Myrbetriq
TABLET, FILM COATED, EXTENDED RELEASE
Astellas Pharma US, Inc.
USA
Myrbetriq 25 mg/1

Myrbetriq 25 mg/1

Mirabegron · 25 mg

Myrbetriq
TABLET, FILM COATED, EXTENDED RELEASE
Astellas Pharma US, Inc.
USA
Myrbetriq 50 mg/1

Myrbetriq 50 mg/1

Mirabegron · 50 mg

Myrbetriq
TABLET, FILM COATED, EXTENDED RELEASE
Astellas Pharma US, Inc.
USA